Healthcare
& Pharma.
Evidence-led growth for regulated categories, from prescription brands to digital health. In this sector, growth is a compliance problem as much as a marketing one, and most agencies only solve one. We build inside the guardrails, so the work is persuasive and defensible in the same sentence.
Pharma, medical devices, clinics and health technology
assembled per engagement, not sold as packages.
India, UAE and United States on one team
medical, legal and regulatory sign-off designed in from the brief, not bolted on at the end
Figures are illustrative and to be confirmed before this page goes live.
The problems we keep meeting.
Six patterns that show up in almost every healthcare and pharma brief that reaches us.
Compliance and marketing pull opposite ways
A claim that lands with patients is a claim legal will not clear. The work has to be persuasive and defensible in the same breath
Evidence is the message, not decoration
Clinicians buy on data, not adjectives. If the proof is not front and centre and correctly caveated, credibility leaves with it.
HCP engagement runs on trust and time
Physicians are time-poor and wary of promotion. Reaching them means earning a place in their workflow, not interrupting it
Long approval cycles, real MLR review
Every asset passes medical, legal and regulatory review. Plan for it and you ship; treat it as an afterthought and the campaign stalls in the queue
Patients arrive already having searched
By the first appointment they have read the forums and formed a view. The category has to meet informed, anxious people where they already are
Sensitive data, guarded by regulation
Health data is siloed by design and bound by consent. Measurement has to respect privacy before it can satisfy a CFO.
Four ways in To this sector.
Each one has its own buyer, its own proof and its own line it cannot cross.
Pharma
Evidence-led brand and HCP engagement for prescription and consumer health, built to clear medical, legal and regulatory review intact. We write for the clinician and the patient without letting either claim outrun the data
Build the claims framework and evidence hierarchy before a word of creative
Design HCP programmes that earn attention inside the clinical workflow
Produce assets that clear medical, legal and regulatory review the first time
How we deliver healthcare.
Brand & Positioning
A position that clears medical and legal review, and still means something to a patient.
Demand & Growth
High-intent patient and HCP demand, measured on qualified enquiry rather than reach, inside consent and privacy rules
Go-to-Market & Launch
Device and therapy launches with the evidence story, the channel assets and MLR sign-off ready before the date
Data & Decision Intelligence
Measurement your compliance team and your CFO both accept, agreed before the spend starts
Digital Platforms & Products
Patient portals, HCP hubs and product surfaces built for trust, accessibility and consent.
AI Transformation
AI in the workflow and the campaign engine, with the audit trail a regulated review will demand.
